Ubs Asset Management Americas Inc Evolus, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 156,565 shares of EOLS stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,565
Previous 115,052
36.08%
Holding current value
$1.55 Million
Previous $1.27 Million
48.27%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EOLS
# of Institutions
187Shares Held
52MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$49.5 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$40.9 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$39.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$36.1 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$32 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $555M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...